DEFA14A ·Filed Apr 28, 2026
Proxy solicitation materials
Actionable Insight • Neutral
No immediate trading action warranted. Monitor upcoming definitive proxy statement for specific proposals, director elections, or shareholder votes that may impact the stock.
Final — all horizons settled through T+60d
EDIT ▼ -7.80% at T+60d
NEUTRAL call -7.80% · α vs SPY -11.91% · entry $2.82 → $2.60
T+1d
+6.38%
call +6.38% · α +5.36%
$3.00
settled 6mo ago
T+5d
+12.59%
call +12.59% · α +9.48%
$3.18
settled 6mo ago
T+20d
+21.63%
call +21.63% · α +15.58%
$3.43
settled 5mo ago
T+60d
-7.80%
call -7.80% · α -11.91%
$2.60
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Editas Medicine filed definitive additional proxy materials (DEFA14A) with no substantive new information disclosed. The filing is administrative in nature and does not reveal any material changes, proposals, or voting matters. The market impact is negligible.
Key Facts
- Filed DEFA14A (definitive additional proxy materials) on 2026-04-28
- No specific proposals, voting items, or financial details disclosed in the filing
- Filer is the registrant (management)
Financial Impact
Not specified
Risk Factors
- Lack of material information - stock may trade on unrelated news
- Potential for hidden activist or dissident activity not reflected in this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
65% bullish (20 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001650664-26-000038 |
| Document: 0001650664-26-000038-index-headers.html | 0001650664-26-000038 |
| Document: 0001650664-26-000038-index.html | 0001650664-26-000038 |
| Document: 0001650664-26-000038.txt | 0001650664-26-000038 |
17 reports for EDIT
60% Hit rate @ T+20 Went positive at some point 9 of 11 best @ T+20▲ +23.25%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G | $2.57 | awaiting T+20 | — | $2.60 (+1.35%) |
Oct 8, 2026 19d ago | 8-K | $2.84 | awaiting T+20 | — | $2.60 (−8.45%) |
Sep 9, 2026 6w ago | EFFECT | $2.77 $2.75 | ▼ −0.72% | ▼ −2.92% | $2.60 (−6.14%) |
Jun 11, 2026 19w ago | Institutional Cluster | $2.44 $3.30 | ▲ +35.25% | ▲ +33.35% | $2.60 (+6.56%) |
May 26, 2026 22w ago | 424B5 | $3.57 $2.74 | ▲ +23.25% | ▲ +21.35% | $2.60 (+27.17%) |
May 26, 2026 22w ago | 8-K | $3.57 $2.74 | ▲ +23.25% | ▲ +21.35% | $2.60 (+27.17%) |
May 26, 2026 22w ago | Press Release | $3.08 $2.83 | ▲ +8.12% | ▲ +6.17% | $2.60 (+15.58%) |
May 26, 2026 22w ago | 8-K | $3.08 $2.83 | ▼ −8.12% | ▼ −6.17% | $2.60 (−15.58%) |
May 26, 2026 22w ago | 424B5 | $3.08 $2.83 | ▲ +8.12% | ▲ +6.17% | $2.60 (+15.58%) |
May 26, 2026 22w ago | Press Release | $3.08 $2.83 | ▲ +8.12% | ▲ +6.17% | $2.60 (+15.58%) |
Showing 10 of 17
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers